Investigating methods of long-term follow-up for patients with Metabolic Syndrome
This project was in partnership with the Canadian Obesity Network. Providence Healthcare has estrablished a reputation as one of the leading centres for cardiovascular research and treatment in Canada. Providence Healthcare and AstraZeneca, a research-based pharmaceutical company, are interested in furthering science and improve patient outcomes. The purpose of this study is to determine the best method of long term follow up for patients with Metabolic Syndrome once they have completed an intensive lifestyle modification program.